News
In an elegant fusion of art and science, researchers at Rice University have achieved a major milestone in nanomaterials ...
Explore how 3D bioprinting is reshaping biotechnology and healthcare by enabling the creation of tissues, organs, and ...
Who owns Samsung? A look at the company's corporate structure, key shareholders, and how the Lee family still controls the ...
Our research looks to bridge the gap between fundamental research and real-world application, fostering an environment where ...
Radioligand Therapy Market To Reach $15.80B by 2033 | DataM Intelligence | Driving Cancer Innovation
Radioligand Therapy Market is set to grow rapidly, rising from $2.41B in 2024 to $15.80B by 2033, driven by advanced cancer treatments and targeted therapies. The U.S. Radioligand Therapy Market is ...
If you’re exploring careers in the life sciences, you’ve likely come across two terms that sound similar but serve distinct ...
Muller, current CEO of Idorsia, to retire and act as an advisor to the company to ensure a smooth transition Allschwil, Switzerland – June Idorsia Ltd (SIX: IDIA) today announced the appointment of Dr ...
Abstracts related to the EACR meeting will be published online following the presentation. For more information, please visit the EACR 2025 website. Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a ...
Purple Biotech Announces Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Platform. News provided by. Purple Biotech Ltd. Jun 04, 2025, 7:00 AM ...
Purple Biotech Announces Poster Presentation At EACR 2025 On Its Novel CAPTN-3 Tri-Specific Antibody Platform. Date. 2025-06-04 07:16:38. Share on Facebook; Tweet on Twitter ...
PanGIA Biotech Announces Upcoming ASCO 2025 Poster Presentation of Collaborative Research. PanGIA Biotech, a company advancing urine-based, AI-driven diagnostics for early cancer detection, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results